Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 crore, with margins improving by 300 basis points to 26%. R&D expenses were Rs 43.7 crore, making up 4.3% of the revenue.
Ceigall India shares rise 4% after winning Rs 705 crore Arunachal Pradesh Frontier Highway project
Ceigall India shares rose 4% after securing a ₹704.7 crore MoRTH contract for the Frontier Highway in Arunachal Pradesh. The EPC project, awarded jointly with